<DOC>
	<DOCNO>NCT00694954</DOCNO>
	<brief_summary>The role capsule endoscopy ( CE ) patient obscure / occult gastrointestinal ( GI ) bleeding remain unclear . This pragmatic randomized control trial design determine diagnostic yield clinical outcome patient obscure GI bleed receive CE compare receive usual standard care .</brief_summary>
	<brief_title>Capsule Endoscopy v Standard Care Obscure Intestinal Bleeding</brief_title>
	<detailed_description>Patients iron deficiency anemia suspect occult GI bleed randomize receive CE usual standard care follow negative gastroscopy colonoscopy . Our primary outcome measure ( diagnostic yield ) secondary outcome measure ( note ) determine one year followup . Patients minimum one year clinical followup . Direct health care cost arm study determine minimum two year followup . An economic evaluation base result clinical trial also plan .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<criteria>1 . Adult patient age 18years iron deficiency anemia ( IDA ) . IDA define hemoglobin &lt; 137g/L men &lt; 120g/L woman serum ferritin level &lt; 22ug/L men &lt; 10ug/L woman . 2 . Eligible patient negative gastroscopy negative colonoscopy within 1 year prior entry study . 3 . Negative celiac screen /or negative small bowel biopsy 1 . Overt gastrointestinal bleeding 2 . Premenopausal woman menorrhagia 3 . Known suspect small bowel obstruction 4 . Serious medical comorbidities preclude surgery give risk capsule impaction 5 . Pregnancy 6 . Inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Iron deficiency anemia</keyword>
	<keyword>Wireless capsule endoscopy</keyword>
	<keyword>Obscure-occult gastrointestinal bleeding</keyword>
</DOC>